Industry Regulations

European Federation of Pharmaceutical Industries and Associations (EFPIA) Code
The EFPIA Code constitutes the collection of ethical rules agreed by EFPIA members for the Promotion of Medicinal Products to HCPs and the interactions with HCPs, HCOs and POs, with the intent of guaranteeing that these activities are conducted while respecting the most stringent ethical principles of professionalism and responsibility. – https://www.efpia.eu/relationships-code/the-efpia-code/

Association of the British Pharmaceutical Industry (ABPI) Code of Practice
The ABPI Code of Practice is a self-regulatory code, first established by the ABPI in 1958. The Code demonstrates the commitment of the pharmaceutical industry to benefiting patients by operating in a professional, ethical and transparent manner, to ensure the appropriate use of medicines and support the provision of high-quality healthcare. – https://www.abpi.org.uk/what-we-do/working-with-industry-and-academia/the-abpi-code-of-practice/

The Prescription Medicines Code of Practice Authority (PMCPA) – http://www.pmcpa.org.uk
PMCPA was established by The Association of the British Pharmaceutical Industry (ABPI) to operate the ABPI Code of Practice for the Pharmaceutical Industry, independently of the ABPI. The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice for the Pharmaceutical Industry independently of the ABPI. It is a not-for-profit body which was established by the ABPI on 1 January 1993. The PMCPA:

• operates the complaints procedure under which the materials and activities of pharmaceutical companies are considered in relation to the requirements of the Code
• provides advice and guidance on the Code
• provides training on the Code
• arranges conciliation between pharmaceutical companies when requested to do so
• scrutinises samples of advertising and meetings to check their compliance with the Code.

Proprietary Association of Great Britain
PAGB operates a pre-publication approval system for member companies’ consumer advertising. It is a condition of membership that all advertising aimed at consumers must be submitted to PAGB for screening and PAGB approval has been given prior to its release into the public domain. PAGB offers advice on advertising that is aimed at health care professionals but does not operate a system of pre-publication approval for such materials. – https://www.pagb.co.uk/

Advertising of medicinal products is governed by the Medicinal Products Statute, approved by Decree-Law no. 176/2006, of August 30th, last amended by Decree-Law no. 26/2018, of April 24th.

APIFARMA – Associação Portuguesa da Indústria Farmacêutica
Tel.: 00 351 21 300 50 80
board@apifarma.pt
www.apifarma.pt

APIFARMA Code of Ethics is available here.

Official Italian Agency for AIFA Procedure
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).

The request of authorization must be submitted within 60 days before the starting date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:

AIM Group International – AIM Education S.r.l.
Cristina Ghidoli
Via G. Ripamonti, 129
20141 Milan, Italy
Tel. +39 02 56601.1
FAX +39 02-70048585
e-mail: aifa@aimgroup.eu